Breast Cancer: Salivary Trp levels are elevated in patients with breast cancer, correlating with tumor aggressiveness and malignancy, particularly in triple-negative and luminal B-like HER2-negative subtypes [114]. Here, ERBB2 is linked to neoplasm.